Related Experiment Video
Updated: Jun 18, 2026
10:37
Transcranial Direct Current Stimulation (tDCS) for Memory Enhancement
Published on: September 18, 2021
Famous forgetters: notable people and Alzheimer's disease
Jeffrey M Jones1, Joni L Jones
1Neurology of Battle Creek, 70 W. Michigan Ave., Battle Creek, MI 49017, USA. jmjones1@voyager.net
American Journal of Alzheimer'S Disease and Other Dementias
|December 2, 2009
Summary
As people live longer, Alzheimer's disease (AD) prevalence increases, posing a significant health challenge. This review examines the growing issue of extended lifespans coupled with age-related cognitive decline, referencing notable individuals.
Area of Science:
- Neuroscience
- Gerontology
- Public Health
Background:
- Increasing global life expectancy is leading to a higher incidence of age-related diseases.
- Alzheimer's disease (AD) represents a major challenge in aging populations, with no current cure.
- The phenomenon mirrors the myth of Tithonus, experiencing prolonged life without sustained youth or vitality.
Purpose of the Study:
- To explore the phenomenon of increased longevity alongside the rising prevalence of Alzheimer's disease.
- To review the impact of Alzheimer's disease on individuals and society.
- To discuss the challenges posed by extended lifespans in the context of neurodegenerative disorders.
Main Methods:
- Literature review of Alzheimer's disease prevalence and aging trends.
- Analysis of case studies or notable individuals affected by Alzheimer's disease.
- Exploration of the societal and personal implications of extended life with cognitive decline.
Main Results:
- Alzheimer's disease prevalence is significantly correlated with increasing life expectancy.
- The lack of a cure for AD exacerbates the challenges of an aging population.
- Notable individuals' experiences highlight the profound personal and societal impact of AD.
Conclusions:
- Addressing the growing prevalence of Alzheimer's disease is critical for public health.
- Further research into AD prevention and treatment is urgently needed.
- Societal strategies must adapt to support longer lifespans impacted by neurodegenerative conditions.
More Related Videos
06:23The 4 Mountains Test: A Short Test of Spatial Memory with High Sensitivity for the Diagnosis of Pre-dementia Alzheimer's Disease
Published on: October 13, 2016
06:48Lexical Decision Task for Studying Written Word Recognition in Adults with and without Dementia or Mild Cognitive Impairment
Published on: June 25, 2019
Related Concept Videos
01:29Alzheimer Disease l: Introduction
Alzheimer disease is a chronic, progressive, and irreversible neurodegenerative disorder and the most common cause of dementia in older adults. It leads to gradual neuronal loss, causing cognitive decline, behavioral changes, and loss of functional independence.Risk Factors and EtiologyThe disease is multifactorial. Age is the strongest risk factor, with prevalence doubling every 5 years after age 65. Genetic factors include mutations in genes such as APP, PSEN1, and PSEN2, which are associated...
01:21Forgetting
Forgetting is an intrinsic aspect of human memory, characterized by the gradual loss or inaccessibility of information over time. Hermann Ebbinghaus, a pioneering psychologist, extensively studied this phenomenon and formulated the forgetting curve. This curve illustrates that memory loss occurs rapidly immediately after learning and then decelerates over time. Several mechanisms contribute to forgetting, including encoding failure, storage decay, retrieval failure, and interference.
Encoding...
Encoding...
01:26Alzheimer's Disease: Overview
Alzheimer's Disease (AD) is a continually advancing neurodegenerative disorder, distinguished by escalating memory loss, cognitive dysfunction, and dementia. The disease unfolds in three stages: preclinical, mild cognitive impairment (MCI), and dementia. Its onset is insidious, and the progression gradual, with the cause not well explained by other disorders.
The clinical diagnosis of AD hinges on the presence of memory and other cognitive impairments. Biomarkers, such as changes in Aβ and tau...
The clinical diagnosis of AD hinges on the presence of memory and other cognitive impairments. Biomarkers, such as changes in Aβ and tau...
01:22Dementia l: Introduction
Dementia is an acquired, progressive syndrome characterized by a decline in multiple cognitive domains severe enough to impair daily functioning and reduce independence. Although memory loss is a central feature, the diagnosis requires additional deficits involving language, executive function, visuospatial skills, judgment, calculation, or abstract reasoning. These cognitive impairments reflect underlying neurodegenerative or vascular processes that gradually disrupt neuronal networks...
01:30Dementia
Dementia is a collective term for cognitive disorders primarily affecting memory, thinking, and reasoning. It is not a specific disease but a syndrome, with Alzheimer's disease being the most common cause, accounting for approximately 60-80% of cases. Other types include vascular dementia, Lewy body dementia, and frontotemporal dementia. Dementia affects millions worldwide, particularly older adults, though it is not a normal part of aging.
The progression of dementia is generally gradual.
The progression of dementia is generally gradual.
01:22Alzheimer's Disease: Treatment
Alzheimer's Disease (AD), a neurodegenerative disorder, is pathologically identified by amyloid plaques and neurofibrillary tangles composed of tau protein. AD pharmacotherapy aims to manage cognitive symptoms, delay disease progression, and treat behavioral symptoms. The treatment is primarily symptomatic and palliative, with no definitive disease-modifying therapy available. Cholinesterase inhibitors, including donepezil (Aricept), rivastigmine (Exelon), and galantamine (Razadyne), are...